George Moukarzel

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

1

Total Citations

11

H-Index

1

About

George Moukarzel is a researcher at the forefront of laboratory automation and high-throughput analytics, with a focus on transforming biochemical assay development for the pharmaceutical industry. His work centers on democratizing automation through open-source, cost-effective robotic solutions, a critical innovation for labs with limited budgets. His most-cited paper, "Automation of biochemical assays using an open-sourced, inexpensive robotic liquid handler" (2024, 11 citations), demonstrates how accessible technology can replicate the performance of expensive commercial systems, enabling broader adoption of high-throughput screening in drug discovery. Moukarzel’s contributions are particularly impactful within the Vaccines Analytical Research and Development (V-AR&D) department, where he has advanced the High Throughput Analytics (HTA) group’s capabilities. By bridging the gap between cutting-edge automation and practical, scalable implementation, he empowers researchers to accelerate assay development and reduce costs. His work not only enhances efficiency in pharmaceutical R&D but also inspires a new generation of scientists to embrace open-source tools for reproducible, high-impact research.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Automation of biochemical assays using an open-sourced, inexpensive robotic liquid handler
11 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago